News Demant A/S Wiener Boerse

Equities

Real-time Estimate Tradegate Other stock markets 14:33:22 01/07/2024 BST			5-day change	1st Jan Change
40.75 ^EUR	-0.27%		0.00%	+2.97%

06-26	Demant Flags Delay in Completion of Communications Business' Strategic Review	MT
05-29	UK’s Competition Regulator Closes Cochlear-Demant Deal	MT

Demant Flags Delay in Completion of Communications Business' Strategic Review	06-26	MT
Demant A/S: Updated timeline for the strategic review of Communications	06-26	AQ
UK’s Competition Regulator Closes Cochlear-Demant Deal	05-29	MT
Denmark's Demant Completes Sale of Cochlear Implants Business	05-21	MT
Demant A/S: Closing of divestment of cochlear implants business	05-21	AQ
Cochlear Limited acquired Oticon Medical A/s from Demant A/S.	05-20	CI
DEMANT : Q1 sales miss; organic growth guidance unchanged	05-06
Transcript : Demant A/S, Q1 2024 Interim Management Statement Call, May 06, 2024	05-06
Hearing Healthcare Company Demant Affirms FY24 Outlook	05-06	MT
Demant A/S: Interim Management Statement for Q1 2024	05-06	AQ
Demant A/S Provides Earnings Guidance for the Year 2024	05-06	CI
Denmark's Demant Finalizes Capital Reduction	04-08	MT
Demant A/S: Completion of capital reduction in Demant A/S	04-08	AQ
Competition Regulator Clears Cochlear’s Acquisition of Oticon Medical’s Cochlear Implant Business	04-04	MT
Demant Seeks Acquisitions	03-12	CI
Transcript : Demant A/S - Analyst/Investor Day	03-12
Demant A/S: Capital Markets Day 2024 - Sharpened focus on Hearing Healthcare	03-12	AQ
Demant A/S: Decisions of Annual General Meeting	03-06	AQ
Nordic Stocks Closed Down Wednesday; Electrolux Series a Posted Biggest Loss	02-28	DJ
Demant A/S: Transactions with Demant shares by Board of Directors and Executive Board and closely related parties	02-28	AQ

No results for this search

DEMANT : Q1 sales miss; organic growth guidance unchanged

May 06, 2024 at 04:18 pm